Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell salvage and leucodepletion.

M H Cross1

  • 1Department of Anaesthesia, The General Infirmary at Leeds, UK.

Perfusion
|May 4, 2001
PubMed
Summary
This summary is machine-generated.

Cell salvage effectively conserves blood but removes few leukocytes. While bedside leucofiltration is generally safe, potential hypotensive events linked to bradykinin production warrant caution.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MRSA, screening and implications for the anaesthetist.

Anaesthesia·2009
Same author

Near-patient testing for coagulopathy after cardiac surgery.

British journal of anaesthesia·2003
Same author

Anaesthesia for cardioversion: a comparison of sevoflurane and propofol.

Anaesthesia·2002
Same author

No response to trigger agents in a malignant hyperthermia-susceptible patient.

British journal of anaesthesia·2002
Same author

Incremental spinal anaesthesia for elective Caesarean section in a patient with Eisenmenger's syndrome.

British journal of anaesthesia·2001
Same author

Autotransfusion in cardiac surgery.

Perfusion·2001
Same journal

Trileaflet mitral valve in hypertrophic obstructive cardiomyopathy: A rare anatomical variant requiring surgical intervention.

Perfusion·2026
Same journal

Corrigendum to: "A comparison of continuous blood gas monitors during cardiopulmonary bypass LivaNova B-capta, terumo CDI 500, spectrum medical M4".

Perfusion·2026
Same journal

ROTEM versus conventional coagulation tests in evaluating coagulopathy and transfusion requirement in ECMO patients: A retrospective study.

Perfusion·2026
Same journal

Safety and efficacy of transcatheter aortic valve replacement (TAVR) vs. surgical aortic valve replacement (SAVR) in patients with bicuspid aortic stenosis: A Systematic review and meta-analysis.

Perfusion·2026
Same journal

External validation of the population pharmacokinetic model of meropenem in patients undergoing neonatal extracorporeal membrane oxygenation and continuous renal replacement therapy.

Perfusion·2026
Same journal

Hydrogen ion (pH) and gas behavior during deep hypothermic cardiopulmonary bypass: Physiology and clinical implications.

Perfusion·2026
See all related articles

Area of Science:

  • Biomedical Engineering
  • Hematology
  • Surgical Innovation

Background:

  • Cell salvage, a blood conservation technique, has been utilized for over 30 years, with significant refinements occurring in the last 25 years.
  • The process, initially involving the Latham bowl, evolved to include washing concentrated red blood cells for a universally acceptable product.
  • While cell salvage aims to remove the buffy coat (platelets and leukocytes), its efficacy in removing these components varies.

Purpose of the Study:

  • To review the effectiveness of cell salvage in removing leukocytes.
  • To examine the clinical significance of residual leukocytes after cell salvage.
  • To assess the safety and potential complications of bedside leucofiltration, particularly for cell-salvaged blood.

Main Methods:

Related Experiment Videos

  • Review of existing literature on cell salvage techniques and outcomes.
  • Analysis of studies reporting leukocyte removal efficiency during cell salvage.
  • Examination of case reports and studies on adverse events associated with bedside leucofiltration.

    • Main Results:

    • Cell salvage demonstrates minimal removal of leukocytes, with remaining cells undergoing morphological changes and increased adhesion receptor expression.
    • There is limited evidence to support significant clinical benefits from removing these activated leukocytes.
    • Bedside leucofiltration, including for cell-salvaged blood, has been associated with hypotensive events, potentially due to bradykinin production.

    Conclusions:

    • Cell salvage is a valuable blood conservation method, but its leukocyte removal capacity is limited.
    • The clinical benefit of removing activated leukocytes post-salvage is not well-established.
    • Caution is advised with bedside leucofiltration due to the risk of hypotension, possibly mediated by bradykinin release.